Research News

  • Black tea and berries could contribute to healthier ageing
    6 May 2025

    Black tea and berries could contribute to healthier ageing

    Higher intakes of black tea, berries, citrus fruits and apples could help to promote healthy ageing, new research has found. This study conducted by researchers from Edith Cowan University, Queen's University Belfast and Harvard T.H. Chan School of Public Health, found that foods rich in flavonoids could help to lower the risk of key components of unhealthy ageing, including frailty, impaired physical function and poor mental health.
  • 6 May 2025
    AI could help improve early detection of interval breast cancers
    A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers — those that develop between routine screenings — before they become more advanced and harder to treat. This could potentially lead to better screening practices, earlier treatment and improved patient outcomes.
  • 5 May 2025
    Antivenom neutralizes the neurotoxins of 19 of the world’s deadliest snakes
    By using antibodies from a human donor with a self-induced hyper-immunity to snake venom, scientists have developed the most broadly effective antivenom to date, which is protective against the likes of the black mamba, king cobra, and tiger snakes in mouse trials.
  • 5 May 2025
    Super strong antibodies developed by scientists for new cancer treatment

    Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease.

  • 1 May 2025
    Largest Osteoarthritis Genetic Study Uncovers Pathways to New Therapies and Repurposed Drugs
    Researchers have uncovered multiple new genes and genetic pathways that could lead to repurposing hundreds of existing drugs for osteoarthritis, the most common form of arthritis. The research, which analyzed data from nearly 2 million people in diverse populations worldwide, was recently published in Nature. It represents an extensive genetic exploration of osteoarthritis, a condition affecting over 600 million people globally.
  • 1 May 2025
    Long-term survival rates of some Acute Myeloid Leukaemia patients could double with sensitive bone marrow test
    A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukaemia by helping doctors identify if they might relapse up to three months earlier. The patient-specific molecular test can detect low levels of leukaemia cells in the body, known as minimal residual disease, which when left untreated causes the disease to relapse.
  • 23 April 2025
    A repurposed anti-inflammatory drug may help treat alcohol use disorder and related pain

    A preclinical study from scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity two issues that commonly co-occur with alcohol use disorder (AUD).

  • 23 April 2025
    Empowering antibodies to better activate the immune system
    Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of the immune system, which then go to work to clear an infection. A new study from Scripps Research explores the factors that influence how effectively antibodies engage specific immune cells.
  • 22 April 2025
    16 years old team of young researchers developed salt-powered mini fridge for vaccine transport and storage

    Team of Young researchers, still in Indian school, developed a portable, electricity-free refrigeration unit using a salt solution to keep vaccines and other temperature-sensitive materials cool. Team consisting of Dhruv Chaudhary, Mithran Ladhania, and Mridul Jain, is known for their work on Thermavault, a device designed to transport vaccines, medicines, and even transplant organs.

  • 21 April 2025
    Integrative approach reveals promising candidates for AD risk factors or targets for treatments

    A study published in the American Journal of Human Genetics by researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital provides solutions to the pressing need to identify factors that influence Alzheimer’s disease (AD) risk or resistance while providing an avenue to explore potential biological markers and therapeutic targets.

Subscribe to Research News